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Elevated mortality after successful tuberculosis treatment 
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There is limited published information on mortality rates after successful completion of 
tuberculosis treatment. While tuberculosis treatment outcomes are routinely recorded, 
monitoring patients after completion of treatment is not recommended in WHO guidelines, 
except for one year post-treatment monitoring of drug-resistant TB patients to identify 
recurrent TB (1,2).
In this issue Shuldiner et al. assessed post-treatment mortality through linkage of the 
national TB registry and civil registry in a cohort of 3250 successfully treated Israeli TB 
patients who had started treatment in the period 2000–2010 (3). These successfully treated 
patients had a 3.7 (95% CI 3.4–4.1) times higher risk of death than the general Israeli 
population. The standardized mortality ratio was highest in the age group 25–44 years and 
somewhat higher among men (4.2) than women (3.2).
Shuldiner et al. suggest that increased mortality after successful tuberculosis treatment may 
be due to pulmonary impairment caused by tuberculosis and/or to shared risk factors, such 
as smoking, for tuberculosis and conditions such as lung cancer. Tuberculosis is more likely 
to occur in patients with underlying conditions such as cancer and diabetes, in patients with 
specific risk factors such as smoking and HIV infection, as well as in those with more 
general socio-economic determinants, owing to living and working conditions with a higher 
risk of exposure to Mycobacterium tuberculosis and less access to high-quality health care 
(4), all of which are also independently associated with increased mortality rates. Thus, it is 
possible that the increased mortality rates post-tuberculosis treatment would reflect the risks 
associated with these other risk factors and underlying conditions rather than lung damage 
after tuberculosis.
Unfortunately, the wide range of causes of deaths identified by Shuldiner et al. suggests that 
an intervention to reduce post tuberculosis mortality may not be easy to find. Further studies 
to determine the causes of post TB treatment mortality, including the possible role of post-
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The findings and conclusions in this article are those of the author(s) and do not necessarily represent the official 
position of the U.S. Centers for Disease Control and Prevention.
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